Inhibrx Biosciences (INBX) Accumulated Depreciation & Amortization (2023 - 2025)
Historic Accumulated Depreciation & Amortization for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $582000.0.
- Inhibrx Biosciences' Accumulated Depreciation & Amortization fell 2342.11% to $582000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $582000.0, marking a year-over-year decrease of 2342.11%. This contributed to the annual value of $2.3 million for FY2024, which is 9185.56% up from last year.
- As of Q3 2025, Inhibrx Biosciences' Accumulated Depreciation & Amortization stood at $582000.0, which was down 2342.11% from $662000.0 recorded in Q2 2025.
- Inhibrx Biosciences' Accumulated Depreciation & Amortization's 5-year high stood at $2.3 million during Q4 2024, with a 5-year trough of $295000.0 in Q2 2023.
- Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $622000.0 (2025), whereas its average is $758900.0.
- As far as peak fluctuations go, Inhibrx Biosciences' Accumulated Depreciation & Amortization skyrocketed by 15000.0% in 2024, and later plummeted by 2342.11% in 2025.
- Quarter analysis of 3 years shows Inhibrx Biosciences' Accumulated Depreciation & Amortization stood at $1.2 million in 2023, then soared by 91.86% to $2.3 million in 2024, then plummeted by 74.53% to $582000.0 in 2025.
- Its Accumulated Depreciation & Amortization was $582000.0 in Q3 2025, compared to $662000.0 in Q2 2025 and $675000.0 in Q1 2025.